MULTISITE EXPERIMENTAL COST STUDY OF INTENSIVE PSYCHIATRIC COMMUNITY CARE

Citation
R. Rosenheck et al., MULTISITE EXPERIMENTAL COST STUDY OF INTENSIVE PSYCHIATRIC COMMUNITY CARE, Schizophrenia bulletin, 21(1), 1995, pp. 129-140
Citations number
19
Categorie Soggetti
Psychiatry,Psychiatry,"Clinical Neurology
Journal title
ISSN journal
05867614
Volume
21
Issue
1
Year of publication
1995
Pages
129 - 140
Database
ISI
SICI code
0586-7614(1995)21:1<129:MECSOI>2.0.ZU;2-9
Abstract
A 2-year experimental cost study of 10 Intensive Psychiatric Community Care (IPCC) programs was conducted at Department of Veterans Affairs (VA) medical centers in the Northeast. High hospital users were random ly assigned to either IPCC (n = 454) or standard VA care (n = 419) at four neuropsychiatric (NP) and six general medical and surgical (GMS) hospitals. National computerized data were used to track all VA health care service usage and costs for 2 years following program entry. At 9 of the 10 sites, IPCC treatment resulted in reduced inpatient servic e usage. Overall, for IPCC patients compared with control patients, av erage inpatient usage was 89 days (33%) less while average cost per pa tient (for IPCC inpatient, and outpatient services) was $15,556 (20%) less. Additionally, costs for IPCC patients compared with control pati ents were $33,295 (29%) less at NP sites but were $6,273 (15%) greater at GMS sites. At both NP and GMS sites, costs were lower for IPCC pat ients in two subgroups: veterans over age 45 and veterans with high le vels of inpatient service use before program entry. No interaction was noted between the impact of IPCC on costs and other clinical or socio demographic characteristics. Similarly, no linear relationship was obs erved between the intensity of IPCC services and the impact of IPCC on VA costs, although the two sites that did not fully implement the IPC C program had the poorest results. With these sites excluded, the tota l cost of care for IPCC patients at GMS sites was $579 (3%) more per y ear than that for the control patients.